Overview

Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Status:
Completed

Trial end date:
2003-02-01

Target enrollment:

Participant gender:

Summary

This study will assess the safety and efficacy of artemether-lumefantrine tablets (6-dose regimen) in African infants / children with acute uncomplicated falciparum malaria.

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Collaborators:

Avenue Appia 20
CH - 1211 Geneva 27
Switzerland
World Health Organization

Treatments:

Artemether
Artemether-lumefantrine combination
Artemether, Lumefantrine Drug Combination
Artemisinins
Lumefantrine